Date: Saturday, November 21, 2026

Time: 09:00-16:00

Venue: De Montil – Moortelstraat 8, 1790 Affligem

Registration Types & Fees

The TechDay will have a “Dutch” and a “French” program. Please choose the correct ticket for you when registering. The fees are of course the same.

Registration will open in June 2026!

Preliminary Program

DUTCH PROGRAM

FRENCH PROGRAM

Please note that this is a Provisional Program. Changes in the program can occur.

FANC/AFCN Accreditation will be requested.

Date: June 09, 2026

Time: 18:00 – 19:30

Venue: Webinar – online via Zoom

— Click here to register now! — 

Can we standardise PSMA PET/CT reporting across Belgium?

Open to all Physicians involved in Management of Prostate Cancer

Organised by the Belgian Association of Nuclear Medicine in

collaboration with BSMO, BeSTRO, BMUC, SBU and BVU.

Register now

The Belgian RLT Summit 2026:
A Unified National Strategy for
Radioligand Therapy

Nederlandse versie (Version française ci-dessous – English version below)

Geachte mevrouw,
Geachte heer,

SCK CEN nodigt u uit voor The Belgian RLT Summit 2026, een interfederaal forum over de toekomst van radioligandtherapie (RLT) in België.

België speelt een sleutelrol in de ontwikkeling en uitrol van RLT, een van de meest veelbelovende innovaties binnen de nucleaire geneeskunde en oncologische zorg. Dankzij een uitzonderlijk sterk en geïntegreerd ecosysteem, van de productie van radio-isotopen en farmaceutische innovatie tot gespecialiseerde ziekenhuiszorg, beschikt ons land over alle troeven om toonaangevend te zijn in Europa.

Met dit forum willen wij beleidsmakers, clinici, academici, industrie en bevoegde autoriteiten samenbrengen om te werken aan een coherente en toekomstgerichte interfederale strategie voor RLT. Onze gezamenlijke ambitie moet zijn om zowel de toegang van patiënten tot deze therapie te waarborgen als de leidende positie van het Belgische ecosysteem te versterken en te bestendigen.

Programma:

09.00 – 09.05: Welkom door Sarah Baatout (SCK CEN)

09.05 – 09.20: Politieke opening door Minister van Energie, Mathieu Bihet

09.20 – 09.35: Wetenschappelijke keynote door Professor Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—

09.35 – 10.05: Panel I – What does it take? (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professor Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) en André Deschamps (Voorzitter Wij Ook)

—

10.35 – 11.15: Panel II – How do we move forward? (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Professor Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professor Piet Dirix (ZAS) en Marie Jacqmin (Les Engagés)

—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—

11.25 – 12.05: Panel III – From political ambition to implementation (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Koen Hasaers (SCK CEN), Professor Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professor Lieselot Brepoels (TRRI) en Wouter Beke (MEP CD&V)

12:05 – 12.15: Closing remarks – Marc Van den Bulcke (Sciensano)

12.15 – 13.00: Netwerklunch

Praktische informatie

• Datum: maandag 30 maart 2026
• Tijdstip: 09.00 – 12.15 uur, gevolgd door een netwerklunch
• Locatie: Paleis der Academiën, Hertogsstraat 1, 1000 Brussel
• Taal: Nederlands en Frans, tolken aanwezig voor simultane vertaling

Wij hopen u op 30 maart te mogen verwelkomen. Gelieve uw aanwezigheid te bevestigen via deze inschrijvingslink.

Ik schrijf me in

Met hoogachting,
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN

Met de steun van Novartis

Version française

Madame,
Monsieur,

Le SCK CEN a le plaisir de vous inviter au Belgian RLT Summit 2026, un forum interfédéral consacré à l’avenir de la radioligand-thérapie (RLT) en Belgique.

La Belgique joue un rôle clé dans le développement et le déploiement de la RLT, l’une des innovations les plus prometteuses en médecine nucléaire et en oncologie. Notre pays est aujourd’hui un leader européen grâce à un écosystème exceptionnellement solide et intégré, allant de la production de radio-isotopes et de l’innovation pharmaceutique aux soins hospitaliers hautement spécialisés.

À travers ce forum, nous souhaitons réunir décideurs politiques, cliniciens, universitaires, acteurs industriels et autorités compétentes afin de travailler à une stratégie interfédérale cohérente et tournée vers l’avenir pour la RLT. Notre ambition commune doit être d’assurer l’accès des patients à cette thérapie tout en renforçant et en consolidant la position de leader de l’écosystème belge.

Programme:

09.00 – 09.05: Mot de bienvenue par Sarah Baatout (SCK CEN)

09.05 – 09.20: Ouverture politique par le Ministre de l’Énergie, Mathieu Bihet

09.20 – 09.35: Keynote scientifique par Professeur Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—

09.35 – 10.05: Panel I – What does it take? (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professeur Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) et André Deschamps (Voorzitter Wij Ook)

—
10:05 – 10:35: Pause
—

10.35 – 11.15: Panel II – How do we move forward? (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Professeur Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professeur Piet Dirix (ZAS) et Marie Jacqmin (Les Engagés)

—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—

11.25 – 12.05: Panel III – From political ambition to implementation (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Koen Hasaers (SCK CEN), Professeur Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professeur Lieselot Brepoels (TRRI) et Wouter Beke (MEP CD&V)

12.05 – 12.15: Mot de clôture – Marc Van den Bulcke (Sciensano)

12.15 – 13.00: Déjeuner de réseautage

Informations pratiques

• Date : lundi 30 mars 2026
• Horaire : 09.00 – 12.15, suivi d’un lunch de réseautage
• Lieu : Palais des Académies, Rue Ducale 1, 1000 Bruxelles
• Langue : néerlandais et français, avec interprétation simultanée

Nous espérons avoir le plaisir de vous accueillir le 30 mars. Nous vous remercions de bien vouloir confirmer votre présence via ce lien d’inscription.

Je m’inscris

Veuillez agréer, Madame, Monsieur, l’expression de nos salutations distinguées.
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN

Avec le soutien de Novartis

English version

Dear Madam, Dear Sir,

SCK CEN is pleased to invite you to The Belgian RLT Summit 2026, an interfederal forum on the future of radioligand therapy (RLT) in Belgium.

Belgium plays a key role in the development and deployment of RLT, one of the most promising innovations in nuclear medicine and oncology care. Thanks to an exceptionally strong and integrated ecosystem, ranging from the production of radioisotopes and pharmaceutical innovation to highly specialised hospital care, our country has all the assets required to be a European leader in this field.

With this forum, we aim to bring together policymakers, clinicians, academics, industry representatives and competent authorities to work towards a coherent and forward-looking interfederal strategy for RLT. Our shared ambition must be to ensure patient access to this therapy while strengthening and consolidating the leading position of the Belgian ecosystem.

Program:

09.00 – 09.05: Welcome by Sarah Baatout (SCK CEN)

09.05 – 09.20: Political opening by the Minister of Energy, Mathieu Bihet

09.20 – 09.35: Scientific keynote by Professor Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—

09.35 – 10.05: Panel I – What does it take? (NL/FR)

Panel discussion moderated by Ingrid Maes (Inovigate) with, among others, Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professor Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) and André Deschamps (Voorzitter Wij Ook)

—
10.05 – 10.35: Break
—

10.35 – 11.15: Panel II – How do we move forward? (NL/FR)

Panel discussion moderated by Ingrid Maes (Inovigate) with, among others, Professor Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professor Piet Dirix (ZAS) and Marie Jacqmin (Les Engagés)

—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—

11.25 – 12.05: Panel III – From political ambition to implementation (NL/FR)

Panel discussion moderated by Ingrid Maes (Inovigate) with, among others Koen Hasaers (SCK CEN), Professor Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professor Lieselot Brepoels (TRRI) and Wouter Beke (MEP CD&V)

12.05 – 12.15: Closing remarks – Marc Van den Bulcke (Sciensano)

12.15 – 13.00: Networking Lunch

Practical information

• Date: Monday, 30 March 2026
• Time: 09.00 – 12.15, followed by a networking lunch
• Venue: Academy Palace, Rue Ducale 1, 1000 Brussels
• Language: Dutch and French, with simultaneous interpretation available

We look forward to welcoming you on the 30th of March. Kindly confirm your attendance via this registration link.

Register here

Yours sincerely,
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN

With the support of Novartis

We would like to welcome our new BELNUC Board that has been elected during our annual BELNUC General Assembly (March 14, 2026)!

• Max LONNEUX has been elected as our new President-elect (2026-2027)
• Stijn VAN HECKE has been elected as our new General Secretary-elect (2026-2027)
• Niloefar AHMADI BIDAKHVIDI has been elected as our new Regular Board Member (2026-2028)

We would like to give some special thanks to Nadia Withofs (President 2024-2025), Vanessa Schelfhout (General Secretary 2024-2025) and Mariana Andrade (Board Member 2023-2025) for their contribution to the BELNUC in their respective positions as Board Members in the past years. 

The current BELNUC Board composition can be found on our BELNUC Board website.

BELNUC Board (March 14, 2026)

Date: September 11-13, 2026

Get ready to unplug and level up! Prepare for a unique glamping weekend fueled by career growth, hands-on learning, and community vibes for young professionals and students passionate about nuclear medicine. Think skill-building workshops, future-focused discussions (yes, including AI), teambuilding under the stars, and connections that actually matter, all set in a chill nature retreat. The new location will be revealed shortly!

Whether you’re a curious student or an early-career resident, this is your chance to discover, connect, and grow in a space that feels more like an experience than a meeting.

More information will follow in due time!

Joint BELNUC–BWGNICI Cardiology Seminar

Cardio-Nuclear Syngery in Practice

Saturday, September 26, 2026

Crown Plaza Brussels Airport

On Saturday, 26 September 2026, BELNUC and BWGNICI will jointly organize a dedicated Cardiology Seminar, bringing together experts in nuclear cardiology and cardiovascular imaging.

This seminar will include state-of-the-art cardiac imaging, interdisciplinary collaboration between nuclear medicine and cardiology, and evolving clinical applications in daily practice. A detailed scientific program, speakers, and registration information will follow.

Registration

The registration will open in June 2026!

Preliminary Program

• Date: Saturday, March 14, 2026

• Venue: Crown Plaza Brussels Airport

CP for RIZIV/INAMI will be requested. CP in Ethics & Economy will be requested^1.   

Accreditation for Hospital Pharmacists (2 points in module 4 & 5) has been granted.

FANC/AFNC has granted:

• 2u00 voor Nuclearisten
• 2u00 voor Stralingsfysicus NG
• 2u00 voor Gemachtigden NG
• 2u00 voor Radiofarmaceuten

The registration is now open! Click here to register now!

Registration will close on March 08, 2026.

BELNUC Members can attend the Seminar free of charge.

BELNUC Non-Members have to pay a fee of 50€ to attend the Seminar.

Please let me remind you that the Seminar fee for BELNUC members is free!

The renewal of the BELNUC Membership via invoice payment may take up to 10 days. Therefore, please make sure to renew your BELNUC membership in due time!

During the General Assembly, there will be votings for the following positions:

• President-elect
• General Secretary-elect
• BELNUC Board Member

The applicants for the positions in the BELNUC Board can be found here.

Only valid BELNUC Members are allowed to participate in the voting process.

The renewal of the BELNUC Membership via invoice payment may take up to 10 days. Therefore, please make sure to renew your BELNUC membership in due time!

Preliminary Program

08:30-08:50: Welcome

08:50-10:00: General Assembly

10:00-10:30: Coffee Break

PIC/S for ^99mTc-based radiopharmaceuticals:

Moderators: Apr. Pieter De Jonghe (AZ Groeninge) & prof. dr. Tim Van den Wyngaert (UZA/UA)

10:35-11:00: Experiences from two centres’ PIC/S journey: From theory to practice – Apr. Nele Cromphout (AZORG)

11:00-12:30: Multi-stakeholder panel discussion on the path towards PIC/S implementation in Belgium

• VBS representative (dr. Raf Verscuren)
• FAGG representative (Margriet Gabriels, Emmanuelle Gay)
• BVZA representative (prof. apr. Thomas De Rijdt)
• BARR representative (prof. apr. Vicky Caveliers)
• Captains of industry (GE & Curium)

This session addresses the implications of implementing PIC/S requirements in nuclear medicine practice through real-world case studies and a multi-stakeholder panel discussion. By presenting the PIC/S implementation journeys of both a small peripheral hospital and a medium-to-large center, the session illustrates how to tackle the challenges of PIC/S with respect to safeguarding patients access and managing economic impact. The subsequent panel discussion with representatives from professional societies (BELNUC, VBS/GBS), regulatory authorities (FAMHP), and industry explores shared accountability, regulatory ethics, cost-effectiveness, and sustainability of services. Together, these components provide participants with practical insight into ethically responsible and economically sustainable decision-making in a highly regulated healthcare environment.

All BELNUC members in good standing are cordially invited to attend the first 2026 seminar as well as the general assembly of our society on Saturday March 14^th , 9:00 – 12:30. Only members in good standing can vote!

Travel/Parking

By Car:

Once on the A201 direction Zaventem Airport take the exit ‘Zaventem Centrum / Da Vinci’. At the roundabout, take the third exit following direction ‘Da Vinci’. Take the first exit left and follow the road through the tunnel. Straight ahead at the next roundabout and the hotel is located on the left.

Satellite Navigation: Da Vincilaan 4, 1831 Diegem

Free parking upon availability!

¹ RIZIV/INAMI accreditation for nuclear medicine physicians is available for BELNUC members only.

The BELNUC Tech Board is urgently looking for technologists that want to join their enthusiastic team and help shape the future of BELNUC activities. 

Are you willing to contribute fresh ideas and assist in the Tech Board activities? Click here to apply for a BELNUC Tech Board Member position!

The renewal for the BELNUC 2026 Membership is now available on the myBELNUC platform!

Further information regarding the membership like membership types, membership fees or advantages of being a BELNUC member can be found on our BELNUC Membership page.

Login to your myBELNUC account and renew your membership today to continue to benefit from your BELNUC membership!